Skip to content

Opening new doors: Hedgehog signaling and the pancreatic cancer stroma

Unknown authors
· 0 citations · 49 references

TL;DR

It is shown that ADAM12 is highly upregulated in the stroma of pancreatic cancer patients and that its expression correlates with stromal marker expression and stromal gene signatures, and bioinformatics as well as in vitro experiments suggest that TGF-β signaling mediates the upregulation of ADAM12.

View source

Similar papers

Review Open access Aug 2026

The tumor microenvironment in pancreatic cancer: from composition to therapeutic targeting

The present review focuses on and discusses the key components of the PDAC TME, with particular emphasis on ECM remodeling, stromal components, their impact on tumor progression and therapeutic resistance, and emerging strategies to target these processes.

B. M. Gomes, P. L. P. Xavier · 0 citations
Review Open access Sep 2026

miR-218 in breast cancer: friend or foe?

miRNAs are small molecules which influence cellular function by regulating the expression of mRNA. They control various stages of the cell’s existence, including differentiation, proliferation and finally death. In cancer cells, miRNAs can become dysregulated, enabling the cell to escape growth suppression and resist...

Mateusz Gotowiec, Marta Wojtkiewicz-Gotowiec, K. Marcinkowska et al. · 0 citations
Review Open access Aug 2026

Multifaceted roles of CD44 in cancer progression and targeted therapeutic strategies

The study reveals that glycosylation and phosphorylation of CD44 regulate its ligand-binding affinity and cell migration, and suggests that targeting CD44, particularly its variant forms, could disrupt cancer stem cell maintenance and metastasis, offering potential therapeutic avenues.

Hyun-Ji Oh, Seung-Tae Kim, Hyun-Jin Kim et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.